Clinical Trials

NCT05711615 | RECRUITING | PHASE1
30 participants

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2024-02-06
Completion:
2026-11-03
Conditions
  • Metastatic Dedifferentiated Liposarcoma
  • Metastatic Leiomyosarcoma
  • Metastatic Myxofibrosarcoma
  • Metastatic Sarcoma
  • Metastatic Synovial Sarcoma
  • Metastatic Undifferentiated Pleomorphic Sarcoma
  • Unresectable Dedifferentiated Liposarcoma
  • Unresectable Leiomyosarcoma
  • Unresectable Myxofibrosarcoma
  • Unresectable Sarcoma
  • Unresectable Synovial Sarcoma
  • Unresectable Undifferentiated Pleomorphic Sarcoma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05691491 | RECRUITING | PHASE1/PHASE2
42 participants

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-09-28
Completion:
2027-03-01
Conditions
  • Advanced Malignant Solid Neoplasm
  • Advanced Microsatellite Stable Colorectal Carcinoma
  • Hematopoietic and Lymphatic System Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Microsatellite Stable Colorectal Carcinoma
  • Stage III Colorectal Cancer AJCC v8
  • Stage IV Colorectal Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05673551 | ENROLLING_BY_INVITATION | NA
220 participants

VR-PAT During Home Burn Dressings - Multisite

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-01-16
Completion:
2027-12-01
Conditions
  • Burns
  • Acute Pain
  • Procedural Pain
  • Injuries
  • Pediatric ALL
Interventions
  • OTHER
No Results Yet
NCT05673200 | SUSPENDED | PHASE1
32 participants

Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-09-25
Completion:
2027-02-23
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05438043 | ACTIVE_NOT_RECRUITING | PHASE3
213 participants

A Study of Daratumumab

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2022-12-15
Completion:
2029-01-31
Conditions
  • Multiple Myeloma
Interventions
  • DRUG
No Results Yet
NCT05372640 | RECRUITING | PHASE1
45 participants

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2023-08-10
Completion:
2027-06-07
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Breast Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic NUT Carcinoma
  • Unresectable Breast Carcinoma
  • Unresectable Malignant Solid Neoplasm
  • Unresectable NUT Carcinoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page